AVDL 8-K 2026-01-12

AVADEL PHARMACEUTICALS PLC (AVDL) 8-K dated 2026-01-12 — accession 0001104659-26-002870. This URL is the filing, not the AVDL hub.

AVADEL PHARMACEUTICALS PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.

AVADEL PHARMACEUTICALS PLC filed a 8-K on 2026-01-12. Accession 0001104659-26-002870.

Cached items: 5.07, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.

Not investment advice. The AVDL SEC hub lists recent forms. The stock page is the research view.